$HCAT News

Stephens & Co. Maintains Equal-Weight on Health Catalyst, Lowers Price Target to $1.75

Health Catalyst, Inc. (HCAT) Q1 2026 Earnings Call Transcript

Health Catalyst (NASDAQ:HCAT) Q1 2026 Revenue Beat, Strategic Reset Fuel 11% Stock Surge

Health Catalyst Sees Q2 Sales $68.000M-$70.000M vs $70.752M Est

Health Catalyst Q1 Adj. EPS $0.02, Inline, Sales $70.756M Beat $69.171M Estimate

Cantor Fitzgerald Suspends Health Catalyst

Health Catalyst Eliminates Chief People Officer Role, Cuts ~9% Workforce, Or ~100 Positions, Under Cost-Reduction Initiative 'Project Nexus'

Wells Fargo Downgrades Health Catalyst to Equal-Weight, Lowers Price Target to $1

Citigroup Maintains Neutral on Health Catalyst, Lowers Price Target to $1.75

Canaccord Genuity Maintains Buy on Health Catalyst, Lowers Price Target to $2

Stephens & Co. Maintains Equal-Weight on Health Catalyst, Lowers Price Target to $2

Health Catalyst shares are trading lower after the company reported mixed Q4 financial results and issued Q1 sales guidance below estimates. Also, Cantor Fitzgerald and Stifel lowered their respective price targets on the stock.

Health Catalyst shares are trading lower after the company reported mixed Q4 financial results and issued Q1 sales guidance below estimates. Also, Cantor Fitzgerald and Stifel lowered their respective price targets on the stock.

Stifel Maintains Hold on Health Catalyst, Lowers Price Target to $2

Cantor Fitzgerald Maintains Neutral on Health Catalyst, Lowers Price Target to $3

Health Catalyst Inc (NASDAQ:HCAT) Reports Mixed Q4 Results and Cautious Outlook, Stock Plunges 15%

Health Catalyst, Inc. (HCAT) Q4 2025 Earnings Call Transcript

Health Catalyst shares are trading lower after the company reported mixed Q4 financial results and issued Q1 sales guidance below estimates.

Health Catalyst Sees Q1 Sales $68.000M-$70.000M vs $74.658M Est

Health Catalyst Q4 Adj. EPS $0.08 Misses $0.09 Estimate, Sales $74.679M Beat $73.984M Estimate